UTSA, Health Science Center Collaborate with Merck & Co., Inc., to Develop Chlamydia Vaccine
April 27, 2009
The University of Texas at San Antonio (UTSA) and The University of Texas Health Science Center at San Antonio (Health Science Center) today announced an exclusive license and sponsored research agreement with Merck & Co., Inc., to develop a vaccine for chlamydia, targeting the common sexually transmitted bacterium Chlamydia trachomatis.
